Form 4: Skye Bioscience Director Sells Shares

Sentiment:

Insider Transaction (Form 4)


Andrew J. Schwab, a Director and 10% owner of Skye Bioscience, Inc., sold 148,079 shares of common stock on September 22, 2026.

Summary

  • Open-market sale: disposed of 27,612 Common Stock at $1.65 ($45,560) on September 22, 2026; holds 114,851 after (Indirect).
  • Open-market sale: disposed of 1,088 Common Stock at $1.65 ($1,795) on September 22, 2026; holds 4,528 after (Indirect).
  • Open-market sale: disposed of 114,851 Common Stock at $1.61 ($184,910) on September 23, 2026 (Indirect).
  • Open-market sale: disposed of 4,528 Common Stock at $1.61 ($7,290) on September 23, 2026 (Indirect).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $239,555 of stock on the open market.

Insider Transactions

Andrew J. Schwab β€” Director, 10% owner

DateTransactionSecuritySharesPriceValueHeld After
2026-09-22Open-market saleCommon Stock27,612$2$45.6K114,851
2026-09-22Open-market saleCommon Stock1,088$2$1.8K4,528
2026-09-23Open-market saleCommon Stock114,851$2$184.9K0
2026-09-23Open-market saleCommon Stock4,528$2$7.3K0

Key Dates

DateDescription
2026-09-22Open-market sale (27,612 shares)
2026-09-22Open-market sale (1,088 shares)
2026-09-23Open-market sale (114,851 shares)
2026-09-23Open-market sale (4,528 shares)

Keywords

insider transaction, Form 4, SKYE, Skye Bioscience, Inc., bearish, Andrew J. Schwab

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.